Approximately 8.9 million individuals in the United States misused opioids in 2023, reflecting the opioid crisis’s devastating impact not only on individuals but also on their families. This qualitative study examines family members’ experiences in supporting loved ones with opioid use disorder (OUD), focusing on their roles, barriers to treatment, and perspectives on medications for opioid use disorder (MOUD). Through in-depth, semi-structured interviews with 15 family members, analyzed using thematic analysis, the findings reveal families as essential providers of care and support while navigating limited resources, exclusion from treatment processes, and their own recovery trajectories. The study findings reveal a need for family-centered approaches, including health care provider training, family-inclusive treatment models, and policy reforms to improve treatment accessibility, reduce systemic barriers, and foster sustainable recovery outcomes for individuals with OUD and their families.
Al GhafriH.HasanN.ElarabiH. F.RadwanD.ShawkyM.Al MamariS.AbdelgawadT.El RashidA.KoderaA.Al KathiriH.LeeA. J.WanigaratneS. (2022). The impact of family engagement in opioid assisted treatment: Results from a randomised controlled trial. International Journal of Social Psychiatry, 68(1), 166–170. https://doi.org/10.1177/0020764020979026
2.
AndoH.CousinsR.YoungC. (2014). Achieving saturation in thematic analysis: Development and refinement of a codebook. Comprehensive Psychology, 3, 03CP34. https://doi.org/10.2466/03.CP.3.4
3.
ArissT.FairbairnC. E. (2020). The effect of significant other involvement in treatment for substance use disorders: A meta-analysis. Journal of Consulting and Clinical Psychology, 88(6), 526–540. https://doi.org/10.1037/ccp0000495
4.
Avery-DesmaraisS.SchulerM.ViveirosJ.McCurryM.TyoM.KauranenB. (2024) Barriers and facilitators to recruitment of a multifaceted population of opioid use disorder community stakeholders. Journal of Addictions Nursing, 35(3), 137–141. https://doi.org/10.1097/JAN.0000000000000586
5.
BagleyS. M.SchoenbergerS. F.WayeK. M.WalleyA. Y. (2019). A scoping review of post opioid-overdose interventions. Preventive Medicine, 128, 105813. https://doi.org/10.1016/j.ypmed.2019.105813
6.
BestD.AnderssonC.IrvingJ.EdwardsM. (2017). Recovery identity and wellbeing: Is it better to be “recovered” or “in recovery”?Journal of Groups in Addiction & Recovery, 12(1), 27–36. https://doi.org/10.1080/1556035X.2016.1272071
7.
BestD.HennessyE. A. (2022). The science of recovery capital: Where do we go from here?Addiction, 117(4), 1139–1145. https://doi.org/10.1111/add.15732
BiegelD. E.IshlerK. J.KatzS.JohnsonP. (2007). Predictors of burden of family caregivers of women with substance use disorders or co-occurring substance and mental disorders. Journal of Social Work Practice in the Addictions, 7(1–2), 25–49. https://doi.org/10.1300/J160v07n01_03
10.
BradshawS. D.ShumwayS. T.WangE. W.HarrisK. S.SmithD. B.Austin-RobillardH. (2015). Hope, readiness, and coping in family recovery from addiction. Journal of Groups in Addiction & Recovery, 10(4), 313–336. https://doi.org/10.1080/1556035X.2015.1099125
11.
BradshawS. D.ShumwayS. T.WangE. W.HarrisK. S.SmithD. B.Austin-RobillardH. (2016). Family functioning and readiness in family recovery from addiction. Journal of Groups in Addiction & Recovery, 11(1), 21–41. https://doi.org/10.1080/1556035X.2015.1104644
12.
BraunV.ClarkeV. (2021). To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qualitative Research in Sport, Exercise and Health, 13(2), 201–216. https://doi.org/10.1080/2159676X.2019.1704846
ChouJ. L.McDowellD.BennettD. S.PattonR.Dilks-WebbK.ZaarurA.SchindlerB. (2024). Family support and medication for opioid use treatment for women: A mixed methods study. Journal of Social Work Practice in the Addictions, 24(1), 63–77. https://doi.org/10.1080/1533256X.2022.2109271
15.
CloudW.GranfieldR. (2008). Conceptualizing recovery capital: Expansion of a theoretical construct. Substance Use & Misuse, 43(12–13), 1971–1986. https://doi.org/10.1080/10826080802289762
16.
CooperS.NielsenS. (2017). Stigma and social support in pharmaceutical opioid treatment populations: A scoping review. International Journal of Mental Health and Addiction, 15(2), 452–469. https://doi.org/10.1007/s11469-016-9719-6
17.
DaleyD. C. (2013). Family and social aspects of substance use disorders and treatment. Journal of Food and Drug Analysis, 21(4 Supplement), S73–S76. https://doi.org/10.1016/j.jfda.2013.09.038
18.
DoppA. R.ManuelJ. K.BreslauJ.LodgeB.HurleyB.KaseC.OsillaK. C. (2022). Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities. Journal of Substance Abuse Treatment, 132, 108652. https://doi.org/10.1016/j.jsat.2021.108652
19.
DutcherL. W.AndersonR.MooreM.Luna-AndersonC.MeyersR. J.DelaneyH. D.SmithJ. E. (2009). Community Reinforcement and Family Training (CRAFT): An effectiveness study. Journal of Behavior Analysis in Health, Sports, Fitness and Medicine, 2(1), 80–90. https://doi.org/10.1037/h0100376
20.
FranciaL.LamT.BergA.MorganK.SavicM.LubmanA. M., D. I.NielsenS. (2023). Alcohol and other drug use: A qualitative exploration of staff and patient’s experiences of language use as a means of stigma communication in hospital and primary care settings. Journal of Substance Use and Addiction Treatment, 149, 209050. https://doi.org/10.1016/j.josat.2023.209050
21.
FriedrichF. S.PasmanE.Boraginna-BallardL.O’ShayS.SzechyK. A.EllisJ. D.ReskoS. M.BrownS. (2023). “Do not carry the load by yourself”: Advice for families affected by non-medical opioid use. Families in Society, 104(3), 262–277. https://doi.org/10.1177/10443894221145759
22.
GranfieldR.CloudW. (2001). Social context and “natural recovery”: The role of social capital in the resolution of drug-associated problems. Substance Use & Misuse, 36(11), 1543–1570. https://doi.org/10.1081/JA-100106963
HanssonK. M.RomørenM.WeimandB.HeiervangK. S.HestmarkL.LandeweerE. G. M.PedersenR. (2022). The duty of confidentiality during family involvement: Ethical challenges and possible solutions in the treatment of persons with psychotic disorders. BMC Psychiatry, 22(1), 812. https://doi.org/10.1186/s12888-022-04461-6
26.
HeathH.CowleyS. (2004). Developing a grounded theory approach: A comparison of Glaser and Strauss. International Journal of Nursing Studies, 41(2), 141–150. https://doi.org/10.1016/S0020-7489(03)00113-5
HeruA. M. (2015). Family-centered care in the outpatient general psychiatry clinic. Journal of Psychiatric Practice®, 21(5), 381–388. https://doi.org/10.1097/PRA.0000000000000097
29.
HintonL.KohrtB. A.KleinmanA. (2019). Engaging families to advance global mental health intervention research. The Lancet: Psychiatry, 6(5), 365–367. https://doi.org/10.1016/S2215-0366(19)30134-8
30.
HogueA.BeckerS. J.WenzelK.HendersonC. E.BobekM.LevyS.FishmanM. (2021). Family involvement in treatment and recovery for substance use disorders among transition-age youth: Research bedrocks and opportunities. Journal of Substance Abuse Treatment, 129, 108402. https://doi.org/10.1016/j.jsat.2021.108402
31.
HogueA.HendersonC. E.BeckerS. J.KnightD. K. (2018). Evidence base on outpatient behavioral treatments for adolescent substance use, 2014–2017: Outcomes, treatment delivery, and promising horizons. Journal of Clinical Child & Adolescent Psychology, 47(4), 499–526. https://doi.org/10.1080/15374416.2018.1466307
32.
JadallaA.PageM.GinexP.ColemanM.VrabelM.BevansM. (2020). Family caregiver strain and burden: A systematic review of evidence-based interventions when caring for patients with cancer. Clinical Journal of Oncology Nursing, 24(1), 31–50. https://doi.org/10.1188/20.CJON.31-50
33.
KaurL.TadrosE.PattonR. (2019). The role of family in youth opioid misuse: A literature review. The Family Journal, 27(4), 429–442. https://doi.org/10.1177/1066480719868705
34.
KellyJ. F.Fallah-SohyN.CristelloJ.BergmanB. (2017). Coping with the enduring unpredictability of opioid addiction: An investigation of a novel family-focused peer-support organization. Journal of Substance Abuse Treatment, 77, 193–200. https://doi.org/10.1016/j.jsat.2017.02.010
35.
KhanN. F.BatemanB. T.LandonJ. E.GagneJ. J. (2019). Association of opioid overdose with opioid prescriptions to family members. JAMA Internal Medicine, 179(9), 1186–1192. https://doi.org/10.1001/jamainternmed.2019.1064
36.
LaudetA. B.MorgenK.WhiteW. L. (2006). Recovery capital as prospective predictor of sustained recovery, life satisfaction, and stress among former poly-substance users. Substance Use & Misuse, 43(1), 27–54. https://doi.org/10.1080/10826080701681473
37.
LeeB.ZhaoW.YangK.-C.AhnY.-Y.PerryB. L. (2021). Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018. JAMA Network Open, 4(2), e2036687. https://doi.org/10.1001/jamanetworkopen.2020.36687
38.
LudwigA.MonicoL. B.LertchE.SchwartzR. P.FishmanM.MitchellS. G. (2021). Until there’s nothing left: Caregiver resource provision to youth with opioid use disorders. Substance Abuse, 42(4), 990–997. https://doi.org/10.1080/08897077.2021.1901178
39.
MaglioneM. A.RaaenL.ChenC.AzharG.ShahidiniaN.ShenM.MaksabedianE.ShanmanR. M.NewberryS.HempelS. (2018). Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review. Journal of Substance Abuse Treatment, 89, 28–51. https://doi.org/10.1016/j.jsat.2018.03.001
40.
MardaniM.AlipourF.RafieyH.Fallahi-KhoshknabM.ArshiM. (2023). Challenges in addiction-affected families: A systematic review of qualitative studies. BMC Psychiatry, 23(1), 439. https://doi.org/10.1186/s12888-023-04927-1
41.
Parlier-AhmadA. B.TerplanM.SvikisD. S.EllisL.MartinC. E. (2021). Recovery capital among people receiving treatment for opioid use disorder with buprenorphine. Harm Reduction Journal, 18(1), Article 1. https://doi.org/10.1186/s12954-021-00553-w
42.
PasmanE.O’ShayS.HicksD.ReskoS. M.AgiusE.BrownS. (2024). Stigma communication surrounding nonmedical opioid use among affected family members. Health Communication, 39(3), 429–438. https://doi.org/10.1080/10410236.2023.2167588
43.
PettersenH.LandheimA.SkeieI.BiongS.BrodahlM.OuteJ.DavidsonL. (2019). How social relationships influence substance use disorder recovery: A collaborative narrative study. Substance Abuse: Research and Treatment, 13, 1–8. https://doi.org/10.1177/1178221819833379
44.
ScorsoneK. L.HaozousE. A.HayesL.CoxK. J. (2020). Overcoming barriers: Individual experiences obtaining medication-assisted treatment for opioid use disorder. Qualitative Health Research, 30(13), 2103–2117. https://doi.org/10.1177/1049732320938689
45.
SlocumS.CarringtonC.PolliniR. A. (2025). “Living in a chronic state of panic”: Family members’ experiences with opioid use disorder. Journal of Social Work Practice in the Addictions, 25(2), 199–215. https://doi.org/10.1080/1533256X.2024.2378687
46.
SolomonP.MolinaroM.MannionE.CantwellK. (2012). Confidentiality policies and practices in regard to family involvement: Does training make a difference?American Journal of Psychiatric Rehabilitation, 15(1), 97–115. https://doi.org/10.1080/15487768.2012.655648
47.
StakeR. E. (2013). Multiple case study analysis. The Guilford Press.
48.
StatonM.PikeE.TillsonM.LofwallM. R. (2024). Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural Appalachia. Journal of Community Psychology, 52(8), 997–1014. https://doi.org/10.1002/jcop.23029
49.
StoneE. M.Kennedy-HendricksA.BarryC. L.BachhuberM. A.McGintyE. E. (2021). The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder. Drug and Alcohol Dependence, 221, 108627. https://doi.org/10.1016/j.drugalcdep.2021.108627
50.
Substance Abuse and Mental Health Services Administration. (2024). Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP23-07-01-006, NSDUH Series H-58). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://samhsa.gov/data/sites/default/files/reports/rpt47095/NationalReport/NationalReport/2023-nsduh-annual-national.pdf
VanderplasschenW.WolfJ.RappR. C.BroekaertE. (2007). Effectiveness of different models of case management for substance-abusing populations. Journal of Psychoactive Drugs, 39(1), 81–95. https://doi.org/10.1080/02791072.2007.10399867
53.
VenturaA. S.BagleyS. M. (2017). To improve substance use disorder prevention, treatment and recovery: Engage the family. Journal of Addiction Medicine, 11(5), 339–341. https://doi.org/10.1097/ADM.0000000000000331
54.
VolkowN. D.FriedenT. R.HydeP. S.ChaS. S. (2014). Medication-assisted therapies—Tackling the opioid-overdose epidemic. The New England Journal of Medicine, 370(22), 2063–2066. https://doi.org/10.1056/NEJMp1402780
55.
WeinsteinZ. M.KimH. W.ChengD. M.QuinnE.HuiD.LabelleC. T.DrainoniM.-L.BachmanS. S.SametJ. H. (2017). Long-term retention in office based opioid treatment with buprenorphine. Journal of Substance Abuse Treatment, 74, 65–70. https://doi.org/10.1016/j.jsat.2016.12.010
56.
WhiteW.CloudW. (2008). Recovery capital: A primer for addictions professionals. Counselor, 9(5), 22–27.
57.
WilkensC.FooteJ. (2019). “Bad parents,” “codependents,” and other stigmatizing myths about substance use disorder in the family. In AveryJ. D.AveryJ. J. (Eds.), The stigma of addiction: An essential guide (pp. 33–53). Springer. https://doi.org/10.1007/978-3-030-02580-9_3
